Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human NT-4 ELISA Kit (AC3657)
Cat.#: ASET-2246
Specifications
Description Human NT-4 ELISA Kit allows for the in vitro quantitative determination of human NT-4 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 56.25 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 93.75-6000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1928 Human VEGFC ELISA Kit (AC3339) Quantitative inquiry ASET-1744 Human Oligodendrocyte Specific Protein ELISA Kit (AC3155) Quantitative inquiry ASET-1757 Human Axin 2 ELISA Kit (AC3168) Quantitative inquiry ASET-2291 Human Wnt5a ELISA Kit (AC3702) Quantitative inquiry ASET-2062 Human SLC26A4 ELISA Kit (AC3473) Quantitative inquiry ASET-1390 Mouse Clathrin Light Chain ELISA Kit (AC2801) Quantitative inquiry ASET-2225 Rat CART ELISA Kit (AC3636) Quantitative inquiry ASET-2478 Human RAMP1 ELISA Kit (AC3889) Quantitative inquiry ASET-1418 Mouse Aromatase ELISA Kit (AC2829) Quantitative inquiry ASET-1878 Human NMDAR2B ELISA Kit (AC3289) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket